Department of Diagnostic Imaging and Nuclear Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Department of Diagnostic Radiology, Hyogo Prefectural Amagasaki General Medical Center, Amagasaki, Japan.
Br J Radiol. 2023 Apr 1;96(1145):20221132. doi: 10.1259/bjr.20221132. Epub 2023 Feb 20.
To evaluate the effectiveness and safety of transcatheter arterial embolization (TAE) of the branches of the subclavian and axillary arteries for hemorrhage control.
Between January 2015 and June 2022, 35 TAE procedures were performed for hemorrhage from the branches of the subclavian and axillary arteries in 34 patients (22 men, 12 women; 1 male underwent TAE twice; mean age = 76 years). Pre-TAE CT showed hematomas in the chest ( = 25) and abdominal walls ( = 3), shoulder ( = 2), and lower neck ( = 2). CT showed hemothorax in eight cases. Angiographic findings, embolization technique, and technical and clinical success of TAE were retrospectively assessed in all cases.
TAE was performed by transfemoral ( = 16), transradial ( = 12), and transbrachial ( = 7) approaches. Angiography revealed contrast media extravasation or pseudoaneurysms in 32 cases (91.4%). The most commonly embolized arteries were the internal thoracic ( = 12), lateral thoracic ( = 6), and thoracoacromial ( = 6) arteries. Technical and clinical success rates were 100 and 85.7%, respectively. A complication (skin necrosis after injection of the liquid embolic agent) developed in only one patient (2.9%) and was conservatively managed.
TAE is an effective and safe treatment for hemorrhage from the branches of the subclavian and axillary arteries.
Transfemoral approach has been used for TAE of the branches of the subclavian and axillary artery. Transradial and transbrachial approaches can also be considered.
评估锁骨下和腋动脉分支经导管动脉栓塞(TAE)治疗出血的效果和安全性。
2015 年 1 月至 2022 年 6 月,对 34 例(男 22 例,女 12 例;1 例男性接受了 2 次 TAE;平均年龄 = 76 岁)锁骨下和腋动脉分支出血患者进行了 35 次 TAE 治疗。TAE 治疗前 CT 显示胸部(=25)、腹壁(=3)、肩部(=2)和颈部下段(=2)有血肿。8 例患者存在血胸。回顾性评估所有患者的 TAE 前 CT 血管造影表现、栓塞技术及 TAE 的技术和临床成功率。
采用经股动脉(=16)、经桡动脉(=12)和经肱动脉(=7)途径进行 TAE。32 例(91.4%)患者的血管造影显示造影剂外渗或假性动脉瘤。最常栓塞的动脉为内乳动脉(=12)、外侧胸动脉(=6)和胸廓肩峰动脉(=6)。技术成功率和临床成功率分别为 100%和 85.7%。仅 1 例(2.9%)患者发生并发症(液体栓塞剂注射后皮肤坏死),并保守治疗。
TAE 是治疗锁骨下和腋动脉分支出血的一种有效且安全的方法。
经股动脉入路已用于锁骨下和腋动脉分支 TAE。也可考虑经桡动脉和肱动脉入路。